Protective Role of Selenium and High Dose Vitamin E against Cisplatin - Induced Nephrotoxicty in Rats |
Aksoy, Asude
(Department of Medical Oncology, Medical Faculty, Firat University)
Karaoglu, Aziz (Department of Medical Oncology, Medical Faculty, Dokuz Eylul University) Akpolat, Nusret (Department of Pathology, Medical Faculty, Inonu University) Naziroglu, Mustafa (Department of Biophysics, Medical Faculty, Suleyman Demirel University) Ozturk, Turkan (Department of Medical Oncology, Medical Faculty, Karadeniz Teknik University) Karagoz, Zuhal Karaca (Department of Internal Medicine-Endocrinology, Elazig Regional Education and Research Hospital) |
1 | Abdel Moneim AE, Othman MS (2014). Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stress. Biomed Res Int, 647131. |
2 | Aebi H (1983). Methods in enzymatic analysis. in catalase, bergmeyer HU (Ed.), academic press, New York, 3, 276-86. |
3 | Antunes LM, Darin JD, Bianchi N de L. (2001). Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res Feb, 43, 145-150. DOI |
4 | Arsenyan P, Paegle E, Domracheva I, Gulbe A, Kanepe-Lapsa I (2014). Shestakova i. selenium analogues of raloxifene as promising antiproliferative agents in treatment of breast cancer. Eur J Med Chem, 87, 471- 83. DOI |
5 | Arunkumar PA, Viswanatha GL, Radheshyam N, et al (2012). Science behind cisplatin-induced nephrotoxicity in humans: a clinical study. Asian Pac J Trop Biomed, 2, 640- 44. DOI |
6 | Atessahin A, Yilmaz S, Karahan I, et al (2005). Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicol, 212, 116-23. DOI |
7 | Brigelius-Flohe R, Kipp A (2009). Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta, 1790, 1555- 68. DOI |
8 | Chirino, YI, Hernandez-Pando R, Pedraza-Chaverri J (2004). Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol, 4, 20-29. DOI |
9 | Dimri K, Pandey AK, Trehan R, et al (2013). Conventional radiotherapy with concurrent weekly Cisplatin in locally advanced head and neck cancers of squamous cell origin-a single institution experience. Asian Pac J Cancer Prev, 14, 6883-88. DOI |
10 | Erten C, Demir L, Somali I, et al (2013). Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients? Asian Pac J Cancer Prev, 14, 3711-17. DOI |
11 | Ferlay J, Soerjomataram I, Dikshit R, et al (2014). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, 359-86. |
12 | Jones DP, Radi R (2014). Redox pioneer: professor helmut sies. Antioxid Redox Signal, 21, 2459-68 DOI |
13 | Fuertes MA, Castilla J, Alanso C, et al (2002). Novel concepts in the development of platinum antitumor drugs. Current Medicinal Chemistry- Anticancer Agents, 2, 539-51. DOI |
14 | Jerome-Morais A, Wright ME, Liu R, Yang W, et al (2012). Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue. Prostate, 72, 1006-12 DOI |
15 | Ji J, Liu J, Liu H, Wang Y (2014). Effects of fermented mushroom of cordyceps sinensis, rich in selenium, on uterine cervix cancer. Evid Based Complement Alternat Med, 2014, 173180. |
16 | Ghorbani A, Omidvar B, Parsi A (2013). Protective effect of selenium on cisplatin induced nephrotoxicity: A double blind controlled randomized clinical trial. J Nephropathol, 2, 129-34. DOI |
17 | Gupta RK, Singh N (2013). Morinda citrifolia (Noni) alters oxidative stress marker and antioxidant activity in cervical cancer cell lines. Asian Pac J Cancer Prev, 14, 4603-6. DOI |
18 | Gurocak S, Karabulut E, Karadag N, et al (2013). Preventive effects of resveratrol against azoxymethane induced damage in rat liver. Asian Pac J Cancer Prev, 14, 2367-70. DOI |
19 | Ha YS, Lee GT, Kim Y H, et al (2014). Decreased seleniumbinding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma. World J Surg Onco, 12, 288. DOI |
20 | Wang J, Liu F, Huang DX, et al (2012). Post-operative treatment with cisplatin and vinorelbine in Chinese patients with nonsmall cell lung cancer: a clinical prospective analysis of 451 patients. Asian Pac J Cancer Prev, 13, 4505-10. DOI |
21 | Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351-58. DOI |
22 | Kappus H, Diplock AT (1992).Tolerance and safety of vitamine E: a toxicological position report. Free Rad Biol Med, 13, 55-74. DOI |
23 | Lawrence RA, Burk RF (1976). Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun, 71, 952-58. DOI |
24 | Martinis BS, Bianchi M de P (2001). Effect of vitamin c supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. Pharmacol Res, 44, 317-20. DOI |
25 | Sedlak J, Lindsay RHC (1968). Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Ellmann’s reagent. Anal Biochem, 25, 192-05. DOI |
26 | Tabacco A, Meiattini F, Moda E, et al (1979). Simplified enzymic/colorimetric serum urea nitrogen determination. Clinical Chemistry, 25, 336-37. |
27 | Weijl NI, Elsendoorn, TJ, Lentjes, EG, et al (2004). Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based hemotherapy: a randomised, double blind, placebo-controlled study. Eur J Cancer, 40, 1713-23. DOI |
28 | Ueda T, Mihara Y, Yoshimina K (1986). Mechanism of cisplatinium neprotoxicity. Jpn J Nephrol, 28, 940-42. |
29 | Yokozawa T, Liu ZW (2000).The role of ginsenoside-Rd in cisplatin-induced acute renal failure. Ren Fail, 22, 115-27. DOI |
30 | Zhao JA, Peng L, Geng CZ, et al (2014). Preventive effect of hydrazine curcumin on carcinogenesis of diethyl nitrosamine-induced hepatocarcinoma in male SD rats. Asian Pac J Cancer Prev, 15, 2115-21. DOI |
31 | Zhuo P, Diamond AM (2009). Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta, 1790, 1546-54. DOI |
![]() |